Viroje Vasusuttikulkant, Chief Executive Officer of SMD Rise Public Company Limited (SET: SMD100), stated that the company’s performance in the second half of 2025 is in line with forecasts, particularly in terms of sales, which have grown as targeted. This reflects the results of ongoing strategic restructuring efforts.
SMD100 second-half sales have been outstanding and exactly as forecasted. The organizational restructuring the company has implemented over the past two years is delivering clear results. If this trend continues, it estimates that in 2026 the company has a solid chance to achieve a net profit in the range of THB 200–300 million with quality returns, said Viroje.
However, he cited that the above estimation is based on current circumstances, which may change depending on the economic environment and relevant external factors. The company will continue to manage risks and closely monitor market trends.
Viroje further emphasized that SMD100 is committed to its “Rooted Growth” strategy, seeking a balance between business performance, social value, and long-term sustainability. The goal is to establish SMD100 as a resilient health organization of the future.
